ALLcrimesfood&drugstaxestelecomcommercehealthconservationtransportationagricultureveteransbrowse all titles »
0

10 U.S.C. § 1107aEmergency use products

submitted 23 years ago by Pub. L. 108-136 to r/title-10-ARMED-FORCES · 421 words · no verdicts yet

in plain englishAI-generated · not legal advice

Only the President may waive, for service members, the emergency-use-product requirement to tell a person that the person may accept or refuse the product, and only with a written national-security determination. If required information cannot be provided before administration, it must be provided afterward within 30 days.

(a) Waiver by the President. (1) When a product authorized for emergency use under section 564 of the Federal Food, Drug, and Cosmetic Act is given to a service member, only the President may waive the condition requiring people to be informed that they may accept or refuse the product. The President may waive it only after deciding in writing that complying with it is not in the interests of national security. (2) This waiver power applies only when a person must be informed of the option to accept or refuse a particular product because the Secretary of Health and Human Services decided that emergency use of the product is authorized under section 564 of that Act. (b) Provision of information. If the President waives that condition and the Secretary of Defense, after consulting the Secretary of Health and Human Services, decides that time limits make it infeasible to give the information described in section 564(e)(1)(A)(ii)(I) or (II) of that Act before administration, the information must be given to the service member, or to the member’s next of kin if the member died, as soon as possible and no later than 30 days afterward. This authority may not be delegated. Information about administration must be recorded in the member’s medical record. (c) Applicability of other provisions. If the Secretary of Health and Human Services authorizes a product under section 564(a)(1) of that Act based on a determination by the Secretary of Defense under section 564(b)(1)(B), subsections (a) through (f) of section 1107 do not apply to using that product within the authorization’s scope while the authorization is effective.
the actual law source: uscode.house.gov ↗public domain
(a)Waiver by the President.—
(1)

In the case of the administration of a product authorized for emergency use under section 564 of the Federal Food, Drug, and Cosmetic Act to members of the armed forces, the condition described in section 564(e)(1)(A)(ii)(III) of such Act and required under paragraph (1)(A) or (2)(A) of such section 564(e), designed to ensure that individuals are informed of an option to accept or refuse administration of a product, may be waived only by the President only if the President determines, in writing, that complying with such requirement is not in the interests of national security.

(2)

The waiver authority provided in paragraph (1) shall not be construed to apply to any case other than a case in which an individual is required to be informed of an option to accept or refuse administration of a particular product by reason of a determination by the Secretary of Health and Human Services that emergency use of such product is authorized under section 564 of the Federal Food, Drug, and Cosmetic Act.

(b)Provision of Information.—

If the President, under subsection (a), waives the condition described in section 564(e)(1)(A)(ii)(III) of the Federal Food, Drug, and Cosmetic Act, and if the Secretary of Defense, in consultation with the Secretary of Health and Human Services, makes a determination that it is not feasible based on time limitations for the information described in section 564(e)(1)(A)(ii)(I) or (II) of such Act and required under paragraph (1)(A) or (2)(A) of such section 564(e), to be provided to a member of the armed forces prior to the administration of the product, such information shall be provided to such member of the armed forces (or next-of-kin in the case of the death of a member) to whom the product was administered as soon as possible, but not later than 30 days, after such administration. The authority provided for in this subsection may not be delegated. Information concerning the administration of the product shall be recorded in the medical record of the member.

(c)Applicability of Other Provisions.—

In the case of an authorization by the Secretary of Health and Human Services under section 564(a)(1) of the Federal Food, Drug, and Cosmetic Act based on a determination by the Secretary of Defense under section 564(b)(1)(B) of such Act, subsections (a) through (f) of section 1107 shall not apply to the use of a product that is the subject of such authorization, within the scope of such authorization and while such authorization is effective.

Source credit: (Added Pub. L. 108–136, div. A, title XVI, § 1603(b)(1), Nov. 24, 2003, 117 Stat. 1689; amended Pub. L. 108–375, div. A, title VII, § 726(b), Oct. 28, 2004, 118 Stat. 1992; Pub. L. 109–364, div. A, title X, § 1071(a)(5), (g)(7), Oct. 17, 2006, 120 Stat. 2398, 2402; Pub. L. 115–91, div. A, title VII, § 716, Dec. 12, 2017, 131 Stat. 1438; Pub. L. 115–92, § 1(c), Dec. 12, 2017, 131 Stat. 2025.)

history & why it existsrecord from the source credit
  • 2003Enacted · Pub. L. 108-136 · 117 Stat. 1689
  • 2004Amended · Pub. L. 108-375 · 118 Stat. 1992
  • 2006Amended · Pub. L. 109-364 · 120 Stat. 2398, 2402
  • 2017Amended · Pub. L. 115-91 · 131 Stat. 1438
  • 2017Amended · Pub. L. 115-92 · 131 Stat. 2025

A history note hasn’t been published yet. The record shows enactment by Pub. L. 108-136 on 2003-11-24.

all 0 arguments · sorted by: best

0/280

no arguments yet — make the first case